Select Publications

Journal articles

Hodges JR; Davies R; Xuereb J; Casey B; Broe M; Bak T; Kril J; Halliday GM, 2004, 'Clinicopathological correlates in frontotemporal dementia', Annals of Neurology, 56, pp. 399 - 406

Kril J; Halliday GM, 2004, 'Clinicopathological staging of frontotemporal dementia severity: correlation with regional atrophy', Dementia and Geriatric Cognitive Disorders, 17, pp. 311 - 315

Mckeith IG; Mintzer J; Aarsland D; Burn D; Chiu H; Cohen-Mansfield J; Dickson D; Dubois B; Dua JE; Feldman H; Gauthier S; Halliday GM; Lawlor B; Lippa C; Lopez O; Machado JC; O Brien J; Playfer J; Reid WG, 2004, 'Dementia with Lewy bodies', Lancet Neurology, 3, pp. 19 - 28

Stanford PM; Brooks WS; Teber E; Hallupp M; McLean CA; Halliday GM; Martins RN; Kwok JB; Schofield PR, 2004, 'Frequency of tau mutations in familial and sporadic frontotemporal dementia and other tauopathies', Journal of Neurology, 251, pp. 1098 - 1104

Huang Y; Cheung L; Rowe DB; Halliday GM, 2004, 'Genetic contributions to Parkinson`s disease', Brain Research Reviews, 46, pp. 44 - 70

Brooks WS; Kwok JB; Halliday GM; Godbolt AK; Rossor MN; Creasey H; Jones A; Schofield PR, 2004, 'Hemorrhage is uncommon in new Alzheimer family with Flemish amyloid precursor protein mutation', Neurology, 63, pp. 1613 - 1617

Harding AJ; Das A; Kril J; Brooks WS; Duffy DL; Halliday GM, 2004, 'Identification of families with cortical Lewy body disease', American Journal of Medical Genetics Part A, 128B, pp. 118 - 122

Henderson JM; Rodriguez M; O Sullivan DJ; Pell MF; Fung VS; Benabid AL; Halliday GM, 2004, 'Partial lesion of thalamic ventral intermediate nucleus after chronic high-frequency stimulation', Movement Disorders, 19, pp. 709 - 711

Shepherd CE; Gregory GC; Vickers J; Brooks WS; Kwok J; Schofield PR; Kril J; Halliday GM, 2004, 'Positional effects of presenilin-1 mutations on tau phosphorylation in cortical plaques', Neurobiology of Disease, 15, pp. 115 - 119

Kersaitis C; Halliday GM; Kril J, 2004, 'Regional and cellular pathology in frontotemporal dementia: relationship to stage of disease in cases with and without Pick bodies', ACTA Neuropathologica, 108, pp. 515 - 523

Kril J; Hodges JR; Halliday GM, 2004, 'Relationship between hippocampal volume and CA1 neuron loss in brains of humans with and without Alzheimer's disease', Neuroscience Letters, 361, pp. 9 - 12

KRIL J, 2004, 'Relationship between hippocampal volume and CA1 neuron loss in brains of humans with and without Alzheimer's disease*1', Neuroscience Letters, 361, pp. 9 - 12, http://dx.doi.org/10.1016/s0304-3940(04)00134-x

Piguet O; Brooks WS; Halliday GM; Schofield PR; Stanford PM; Kwok JB; Spillantini M; Yancopoulou D; Nestor PJ; Broe G; Hodges JR, 2004, 'Similar early clinical presentations in familial and non-familial frontotemporal dementia', Journal of Neurosurgery, 75, pp. 1743 - 1745

Poon TSC; Kuchel JM; Badruddin A; Halliday GM; Barnetson RS; Iwaki H; Hatao M, 2003, 'Objective measurement of minimal erythema and melanogenic doses using natural and solar-simulated light', PHOTOCHEMISTRY AND PHOTOBIOLOGY, 78, pp. 331 - 336, http://dx.doi.org/10.1562/0031-8655(2003)078<0331:OMOMEA>2.0.CO;2

Byrne SN; Halliday GM, 2003, 'Phagocytosis by dendritic cells rather than MHC IIhigh macrophages is associated with skin tumour regression', INTERNATIONAL JOURNAL OF CANCER, 106, pp. 736 - 744, http://dx.doi.org/10.1002/ijc.11274

Kuchel JM; Barnetson RS; Halliday GM, 2003, 'Nitric oxide appears to be a mediator of solar-simulated ultraviolet radiation-induced immunosuppression in humans', JOURNAL OF INVESTIGATIVE DERMATOLOGY, 121, pp. 587 - 593, http://dx.doi.org/10.1046/j.1523-1747.2003.12415.x

Poon TSC; Barnetson RS; Halliday GM, 2003, 'Prevention of immunosuppression by sunscreens in humans is unrelated to protection from erythema and dependent on protection from ultraviolet A in the face of constant ultraviolet B protection', JOURNAL OF INVESTIGATIVE DERMATOLOGY, 121, pp. 184 - 190, http://dx.doi.org/10.1046/j.1523-1747.2003.12317.x

Byrne SN; Halliday GM, 2003, 'High levels of Fas ligand and MHC class II in the absence of CD80 or CD86 expression and a decreased CD4(+) T cell Infiltration, enables murine skin tumours to progress', CANCER IMMUNOLOGY IMMUNOTHERAPY, 52, pp. 396 - 402, http://dx.doi.org/10.1007/s00262-003-0380-0

Agar NS; Halliday GM; Barnetson RS; Jones AM, 2003, 'A novel technique for the examination of skin biopsies by laser capture microdissection', JOURNAL OF CUTANEOUS PATHOLOGY, 30, pp. 265 - 270, http://dx.doi.org/10.1046/j.0303-6987.2003.052.x

Bennett HP; Piguet O; Grayson DA; Creasey H; Waite LM; Broe T; Halliday GM, 2003, 'A 6-year study of cognition and spatial function in the demented and non-demented elderly: The Sydney Older Persons Study', Dementia and Geriatric Cognitive Disorders, 16, pp. 181 - 186

Caramins M; Halliday GM; McCusker E; Trent RJ, 2003, 'Genetically confirmed clinical Huntingdon`s disease with no observable cell loss', Journal of Neurology Neurosurgery and Psychiatry, 74, pp. 968 - 970

Halliday GM; Double KL; Macdonald V; Kril J, 2003, 'Identifying severely atrophic cortical subregions in Alzheimer's disease', Neurobiology of Aging, 24, pp. 797 - 806

Double KL; Rowe DB; Hayes M; Chan DK; Blackie J; Corbett AJ; Joffe R; Fung VS; Morris JG; Halliday GM, 2003, 'Identifying the pattern of olfactory deficits in Parkinson disease using the brief smell identification test', Archives of Neurology, 60, pp. 545 - 549

Stanford PM; Shepherd CE; Halliday GM; Brooks WS; Schofield PR, 2003, 'Mutations in the tau gene that cause an increase in three repeat tau and frontotemporal dementia', Brain, 126, pp. 814 - 826

Henderson JM; Lu Y; Wang SS; Cartwright HR; Halliday GM, 2003, 'Olfactory deficits and sleep disturbance in Parkinson`s disease: a case-control survey', Journal of Neurology Neurosurgery and Psychiatry, 74, pp. 956 - 958

Kwok JB; Halliday GM; Brooks WS; Dolios G; Laudon H; Murayama O; Hallupp M; Vickers J; Wang R; Naslund J; Takashima A; Gandy SE; Badenhop RF; Schofield PR, 2003, 'Presenilin-1 mutation L271V results in altered exon 8 splicing and Alzheimer's disease with non-cored plaques and no neuritic dystrophy', The Journal of Biological Chemistry, 278, pp. 6748 - 6754

Henderson JM; Watson S; Halliday GM; Heinemann T; Gerlach M, 2003, 'Relationships between various behavioural abnormalities and nigrostriatal dopamine depletion in the unilateral 6-OHDA-lesioned rat', Behavioural Brain Research, 139, pp. 105 - 113

Schofield E; Kersaitis C; Shepherd CE; Kril J; Halliday GM, 2003, 'Severity of gliosis in Pick`s disease and frontotemporal lobar degeneration: tau-positive glia differentiate these disorders', Brain, 126, pp. 827 - 840

Broe M; Hodges JR; Schofield E; Shepherd CE; Kril J; Halliday GM, 2003, 'Staging disease severity in pathologically confirmed cases of frontotemporal dementia', Neurology, 60, pp. 1005 - 1011

Hodges JR; Davies RI; Xuereb J; Kril J; Halliday GM, 2003, 'Survival in frontotemporal dementia', Neurology, 61, pp. 349 - 354

Double KL; Halliday GM; Henderson J; Griffiths F; Heinemann T; Riederer P; Gerlach M, 2003, 'The dopamine receptor agonist lisuride attenuates iron-mediated dopaminergic neurodegeneration', Experimental Neurology, 184, pp. 530 - 535

Harasty JA; Seldon H; Chan PP; Halliday GM; Harding AJ, 2003, 'The left human speech-processing cortex is thinner but longer than the right', Laterality, 8, pp. 247 - 260

Kuchel JM; Halliday GM; Barnetson RS, 2002, 'Sunlight and the Mantoux reaction', TROPICAL DOCTOR, 32, pp. 231 - 232, http://dx.doi.org/10.1177/004947550203200417

Byrne SN; Spinks N; Halliday GM, 2002, 'Ultraviolet A irradiation of C57BL/6 mice suppresses systemic contact hypersensitivity or enhances secondary immunity depending on dose', JOURNAL OF INVESTIGATIVE DERMATOLOGY, 119, pp. 858 - 864, http://dx.doi.org/10.1046/j.1523-1747.2002.00261.x

Damian DL; Halliday GM, 2002, 'Measurement of ultraviolet radiation-induced suppression of recall contact and delayed-type hypersensitivity in humans', METHODS, 28, pp. 34 - 45, http://dx.doi.org/10.1016/S1046-2023(02)00208-6

Kwok J; Hallupp M; Badenhop RF; Schofield PR; Halliday GM; Brooks WS; Dolois G; Wang R; Murayama O; Takashima A; Vickers J; Gandy SE, 2002, 'Presenilin-1 mutation (L271V) results in altered exon 8 splicing and Alzheimer's disease with non-cored plaques and no neuritic dystrophy', NEUROBIOLOGY OF AGING, 23, pp. S277 - S277, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000177465301016&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kuchel JM; Barnetson RSC; Halliday GM, 2002, 'Ultraviolet a augments solar-simulated ultraviolet radiation-induced local suppression of recall responses in humans', JOURNAL OF INVESTIGATIVE DERMATOLOGY, 118, pp. 1032 - 1037, http://dx.doi.org/10.1046/j.1523-1747.2002.01773.x

Berhane T; Halliday GM; Cooke B; Barnetson RS, 2002, 'Inflammation is associated with progression of actinic keratoses to squamous cell carcinomas in humans', BRITISH JOURNAL OF DERMATOLOGY, 146, pp. 810 - 815, http://dx.doi.org/10.1046/j.1365-2133.2002.04720.x

Yuen KS; Nearn MR; Halliday GM, 2002, 'Nitric oxide-mediated depletion of Langerhans cells from the epidermis may be involved in UVA radiation-induced immunosuppression', NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 6, pp. 313 - 318, http://dx.doi.org/10.1006/niox.2001.0414

Orr CF; Rowe DB; Halliday GM, 2002, 'An inflammatory review of Parkinson`s disease', Progress in Neurobiology, 68, pp. 325 - 340

Harding AJ; Stimson E; Henderson JM; Halliday GM, 2002, 'Clinical correlates of selective pathology in the amygdaa of patients with Parkinson`s disease', Brain, 125, pp. 2431 - 2445

Hardman CD; Henderson JM; Finkelstein DI; Horne M; Paxinos G; Halliday GM, 2002, 'Comparison of the basal ganglia in rats, marmosets, macaques, baboons, and humans: volume and neuronal number for the output, internal relay, and striatal modulating nuclei', Journal of Comparative Neurology, 445, pp. 238 - 255

Halliday GM; Ng T; Rodriguez M; Harding AJ; Blumbergs P; Evans W; Fabian V; Fryer J; Gonzales M; Harper C; Kalnins RM; Masters CL; Mclean C; Milder DG; Pamphlett R; Scott G; Tannenberg T; Kril J, 2002, 'Consensus neuropathological diagnosis of common dementia syndromes: testing and standardising the use of multiple diagnostic criteria', ACTA Neuropathologica, 104, pp. 72 - 78

Cordato N; Pantelis C; Halliday GM; Velakoulis D; Wood SJ; Stuart GW; Currie J; Soo M; Olivieri G; Broe T; Morris JG, 2002, 'Frontal atrophy correlates with behavioural changes in progressive supranuclear palsy', Brain, 125, pp. 789 - 800

Munch G; Shepherd CE; Mccann H; Brooks WS; Kwok JB; Arendt T; Hallupp M; Schofield PR; Martins RN; Halliday GM, 2002, 'Intraneuronal advanced glycation endproducts in presenilin-l Alzheimer's disease', Neuroreport, 13, pp. 601 - 604

Shepherd CE; Mccann H; Kettle E; Halliday GM, 2002, 'Neurofilament-immunoreactive neurons in Alzheimer's disease and dementia with Lewy Bodies', Neurobiology of Disease, 9, pp. 249 - 257

Kril J; Patel S; Harding AJ; Halliday GM, 2002, 'Neuron loss from the hippocampus of Alzheimer's disease exceeds extracellular neurofibrillary tangle formation', ACTA Neuropathologica, 103, pp. 370 - 376

Kril J; Patel S; Harding AJ; Halliday GM, 2002, 'Patients with vascular dementia due to microvascular pathology have significant hippocampal neuronal loss', Journal of Neurology Neurosurgery and Psychiatry, 72, pp. 747 - 751

Henderson JM; Pell MF; O Sullivan DJ; Mccusker E; Fung VS; Hedges P; Halliday GM, 2002, 'Postmortem analysis of bilateral subthalamic electrode implants in Parkinson`s Disease', Movement Disorders, 17, pp. 133 - 137

Henderson JM; Pell M; O'Sullivan DJ; McCusker EA; Fung VSC; Hedges P; Halliday GM, 2002, 'Postmortem analysis of bilateral subthalamic electrode implants in Parkinson's disease.', Mov Disord, 17, pp. 133 - 137, http://dx.doi.org/10.1002/mds.1261


Back to profile page